Drug intelligence / Profile preview

murine PDL1 antibody

Development stage
Preclinical
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intraperitoneal
01

Overview

Murine PDL1 antibody (also referred to as anti-mouse PD-L1 antibody) is a research-use-only monoclonal antibody designed to target and block murine programmed cell death 1 ligand 1 (PD-L1, CD274). In preclinical research, humanized or fully human anti-PD-L1 antibodies (such as atezolizumab) often lack cross-reactivity with mouse PD-L1 or trigger immunogenic responses in immunocompetent mice. Therefore, surrogate murine PD-L1 antibodies (such as clones 10F.9G2 or MIH6) are widely utilized in syngeneic mouse models to investigate the therapeutic efficacy, mechanism of action, and synergistic potential of PD-1/PD-L1 pathway blockade in combination with other oncology treatments.

Other names
anti-mouse PD-L1 antibodyanti-mouse PDL1 antibodyanti-murine PD-L1 antibodyanti-murine PDL1 antibodymurine PD-L1 antibodymurine PDL1-Antibody
02

Targets

CD274 (Programmed cell death protein 1 ligand 1)

Beyond the preview

Go deeper on murine PDL1 antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on murine PDL1 antibody.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call